A NOVEL RADIOLIGAND [I-125] BQ-3020 SELECTIVE FOR ENDOTHELIN (ETB) RECEPTORS

被引:77
作者
IHARA, M [1 ]
SAEKI, T [1 ]
FUKURODA, T [1 ]
KIMURA, S [1 ]
OZAKI, S [1 ]
PATEL, AC [1 ]
YANO, M [1 ]
机构
[1] AMERSHAM INT PLC,AMERSHAM HP7 9LL,BUCKS,ENGLAND
关键词
D O I
10.1016/0024-3205(92)90418-O
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A linear endothelin (ET) analog, N-acetyl-LeuMetAspLysGluAlaValTyrPheAlaHisLeuAspIleIleTrp (BQ-3020), is highly selective for ETB receptors. BQ-3020 displaces [I-125]ET-1 binding to ET(B) receptors (nonselective to ET isopeptides) in porcine cerebellar membranes (IC50: 0.2nM) at a concentration 4,700 times lower than that to ET(A) receptors (selective to ET-1) on aortic vascular smooth muscle cells (VSMC) (IC50: 940nM). BQ-3020 as well as ET-1 and ET-3 elicits vasoconstriction in the rabbit pulmonary artery. The ET(A) antagonist BQ-123 failed to inhibit this BQ-3020-induced vasocontraction. Furthermore, BQ-3020 elicits endothelium-dependent vasodilation. These data indicate that BQ-3020 has ET(B) agonistic activity. The radioligand [I-125]BQ-3020 binds to cerebellar membranes at single high affinity sites (Kd= 34.4pM), whereas it scarcely binds to VSMC. [I-125]BQ-3020 binding to the cerebellum was displaced by BQ-3020, ET-1 and ET-3 in a nonselective manner (IC50: 0.07-0.17nM). However, the binding of [I-125]BQ-3020 was insensitive to the ET(A) antagonist BQ-123 and other bioactive peptides. Both [I-125]ET-1 and [I-125]BQ-3020 show slow onset and offset binding kinetics to ET(B) receptors. These data indicate that the radioligand [I-125]BQ-3020 selectively labels ET(B) receptors and that the slow binding kinetics of ET-1 are dependent on the peptide sequence from LeU6 to Trp21, but not on the structure formed by its two disulfide bridges.
引用
收藏
页码:PL47 / PL52
页数:6
相关论文
共 18 条
[1]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[2]  
CASEY PJ, 1988, J BIOL CHEM, V263, P2577
[3]  
ELSHOURBAGY NA, 1992, MOL PHARMACOL, V41, P465
[4]   ANALYSIS OF RESPONSES TO ENDOTHELINS IN ISOLATED PORCINE BLOOD-VESSELS BY USING A NOVEL ENDOTHELIN ANTAGONIST, BQ-153 [J].
FUKURODA, T ;
NISHIKIBE, M ;
OHTA, Y ;
IHARA, M ;
YANO, M ;
ISHIKAWA, K ;
FUKAMI, T ;
IKEMOTO, F .
LIFE SCIENCES, 1992, 50 (15) :PL107-PL112
[5]   BINDING OF [I-125] ENDOTHELIN-1 TO RAT CEREBELLAR HOMOGENATES AND ITS INTERACTIONS WITH SOME ANALOGS [J].
HILEY, CR ;
JONES, CR ;
PELTON, JT ;
MILLER, RC .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (02) :319-324
[6]   CELLULAR MECHANISM OF ACTION BY A NOVEL VASOCONSTRICTOR ENDOTHELIN IN CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS [J].
HIRATA, Y ;
YOSHIMI, H ;
TAKATA, S ;
WATANABE, TX ;
KUMAGAI, S ;
NAKAJIMA, K ;
SAKAKIBARA, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (03) :868-875
[7]   BIOLOGICAL PROFILES OF HIGHLY POTENT NOVEL ENDOTHELIN ANTAGONISTS SELECTIVE FOR THE ETA RECEPTOR [J].
IHARA, M ;
NOGUCHI, K ;
SAEKI, T ;
FUKURODA, T ;
TSUCHIDA, S ;
KIMURA, S ;
FUKAMI, T ;
ISHIKAWA, K ;
NISHIKIBE, M ;
YANO, M .
LIFE SCIENCES, 1992, 50 (04) :247-255
[8]   AN ENDOTHELIN RECEPTOR (ETA) ANTAGONIST ISOLATED FROM STREPTOMYCES-MISAKIENSIS [J].
IHARA, M ;
FUKURODA, T ;
SAEKI, T ;
NISHIKIBE, M ;
KOJIRI, K ;
SUDA, H ;
YANO, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (01) :132-137
[9]   THE HUMAN ENDOTHELIN FAMILY - 3 STRUCTURALLY AND PHARMACOLOGICALLY DISTINCT ISOPEPTIDES PREDICTED BY 3 SEPARATE GENES [J].
INOUE, A ;
YANAGISAWA, M ;
KIMURA, S ;
KASUYA, Y ;
MIYAUCHI, T ;
GOTO, K ;
MASAKI, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2863-2867
[10]   COLOR TEST FOR DETECTION OF FREE TERMINAL AMINO GROUPS IN SOLID-PHASE SYNTHESIS OF PEPTIDES [J].
KAISER, E ;
COLESCOT.RL ;
BOSSINGE.CD ;
COOK, PI .
ANALYTICAL BIOCHEMISTRY, 1970, 34 (02) :595-&